Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 32

1.

Platelet glycoprotein VI and C-type lectin-like receptor 2 deficiency accelerates wound healing by impairing vascular integrity in mice.

Wichaiyo S, Lax S, Montague SJ, Li Z, Grygielska B, Pike JA, Haining EJ, Brill A, Watson SP, Rayes J.

Haematologica. 2019 Feb 7. pii: haematol.2018.208363. doi: 10.3324/haematol.2018.208363. [Epub ahead of print]

2.

Functional significance of the platelet immune receptors GPVI and CLEC-2.

Rayes J, Watson SP, Nieswandt B.

J Clin Invest. 2019 Jan 2;129(1):12-23. doi: 10.1172/JCI122955. Epub 2019 Jan 2. Review.

3.

Weight Regain After Sleeve Gastrectomy: A Look at the Benefits of Re-sleeve.

Saliba C, El Rayes J, Diab S, Nicolas G, Wakim R.

Cureus. 2018 Oct 14;10(10):e3450. doi: 10.7759/cureus.3450.

4.

Prevention of the anti-factor VIII memory B-cell response by inhibition of Bruton tyrosine kinase in experimental hemophilia A.

Delignat S, Russick J, Gangadharan B, Rayes J, Ing M, Voorberg J, Kaveri SV, Lacroix-Desmazes S.

Haematologica. 2019 May;104(5):1046-1054. doi: 10.3324/haematol.2018.200279. Epub 2018 Dec 13.

5.

Surgical Approach to a Post-traumatic Fat Fracture.

El Khoury J, Adams D, Saliba C, El Rayes J, Massin A, Fenoll C.

Cureus. 2018 Sep 27;10(9):e3378. doi: 10.7759/cureus.3378.

6.

Biologically Enhanced Hamstring Tendon Transfer for Treatment of Acute Rupture of Posterior Tibialis Tendon in an Athlete: Case Report.

El Rayes J, Bou Sader R, Moutran M, Rassi S, Boueri W.

J Foot Ankle Surg. 2018 Nov 15. pii: S1067-2516(18)30290-4. doi: 10.1053/j.jfas.2018.07.014. [Epub ahead of print]

PMID:
30448181
7.

Salmonella-induced thrombi in mice develop asynchronously in the spleen and liver and are not effective bacterial traps.

Beristain-Covarrubias N, Perez-Toledo M, Flores-Langarica A, Zuidscherwoude M, Hitchcock JR, Channell WM, King LDW, Thomas MR, Henderson IR, Rayes J, Watson SP, Cunningham AF.

Blood. 2019 Feb 7;133(6):600-604. doi: 10.1182/blood-2018-08-867267. Epub 2018 Nov 6.

PMID:
30401709
8.

Inhibitor Formation in Congenital Hemophilia A: an Immunological Perspective.

Delignat S, Rayes J, Russick J, Kaveri SV, Lacroix-Desmazes S; ABIRISK consortium.

Semin Thromb Hemost. 2018 Sep;44(6):517-530. doi: 10.1055/s-0038-1657777. Epub 2018 Jun 4. Review.

PMID:
29864775
9.

Podoplanin: An emerging cancer biomarker and therapeutic target.

Krishnan H, Rayes J, Miyashita T, Ishii G, Retzbach EP, Sheehan SA, Takemoto A, Chang YW, Yoneda K, Asai J, Jensen L, Chalise L, Natsume A, Goldberg GS.

Cancer Sci. 2018 May;109(5):1292-1299. doi: 10.1111/cas.13580. Review.

10.

Absence of a neutralizing antibody response to humanized cobra venom factor in mice.

Ing M, Hew BE, Fritzinger DC, Delignat S, Lacroix-Desmazes S, Vogel CW, Rayes J.

Mol Immunol. 2018 May;97:1-7. doi: 10.1016/j.molimm.2018.02.018. Epub 2018 Mar 8.

PMID:
29525557
11.

Origin-Specific Adhesive Interactions of Mesenchymal Stem Cells with Platelets Influence Their Behavior After Infusion.

Sheriff L, Alanazi A, Ward LSC, Ward C, Munir H, Rayes J, Alassiri M, Watson SP, Newsome PN, Rainger GE, Kalia N, Frampton J, McGettrick HM, Nash GB.

Stem Cells. 2018 Jul;36(7):1062-1074. doi: 10.1002/stem.2811. Epub 2018 Mar 23.

12.

Effect of anti-podoplanin antibody administration during lipopolysaccharide-induced lung injury in mice.

Lax S, Rayes J, Thickett DR, Watson SP.

BMJ Open Respir Res. 2017 Nov 8;4(1):e000257. doi: 10.1136/bmjresp-2017-000257. eCollection 2017.

13.

The contribution of platelet glycoprotein receptors to inflammatory bleeding prevention is stimulus and organ dependent.

Rayes J, Jadoui S, Lax S, Gros A, Wichaiyo S, Ollivier V, Denis CV, Ware J, Nieswandt B, Jandrot-Perrus M, Watson SP, Ho-Tin-Noé B.

Haematologica. 2018 Jun;103(6):e256-e258. doi: 10.3324/haematol.2017.182162. Epub 2018 Feb 1. No abstract available.

14.

The podoplanin-CLEC-2 axis inhibits inflammation in sepsis.

Rayes J, Lax S, Wichaiyo S, Watson SK, Di Y, Lombard S, Grygielska B, Smith SW, Skordilis K, Watson SP.

Nat Commun. 2017 Dec 21;8(1):2239. doi: 10.1038/s41467-017-02402-6.

15.

Complement C3 is a novel modulator of the anti-factor VIII immune response.

Rayes J, Ing M, Delignat S, Peyron I, Gilardin L, Vogel CW, Fritzinger DC, Frémeaux-Bacchi V, Kaveri SV, Roumenina LT, Lacroix-Desmazes S.

Haematologica. 2018 Feb;103(2):351-360. doi: 10.3324/haematol.2017.165720. Epub 2017 Nov 16.

16.

Platelet CLEC-2 protects against lung injury via effects of its ligand podoplanin on inflammatory alveolar macrophages in the mouse.

Lax S, Rayes J, Wichaiyo S, Haining EJ, Lowe K, Grygielska B, Laloo R, Flodby P, Borok Z, Crandall ED, Thickett DR, Watson SP.

Am J Physiol Lung Cell Mol Physiol. 2017 Dec 1;313(6):L1016-L1029. doi: 10.1152/ajplung.00023.2017. Epub 2017 Aug 24.

17.

Complement Factor H Inhibits CD47-Mediated Resolution of Inflammation.

Calippe B, Augustin S, Beguier F, Charles-Messance H, Poupel L, Conart JB, Hu SJ, Lavalette S, Fauvet A, Rayes J, Levy O, Raoul W, Fitting C, Denèfle T, Pickering MC, Harris C, Jorieux S, Sullivan PM, Sahel JA, Karoyan P, Sapieha P, Guillonneau X, Gautier EL, Sennlaub F.

Immunity. 2017 Feb 21;46(2):261-272. doi: 10.1016/j.immuni.2017.01.006.

18.

Endothelial cells: source, barrier, and target of defensive mediators.

Roumenina LT, Rayes J, Frimat M, Fremeaux-Bacchi V.

Immunol Rev. 2016 Nov;274(1):307-329. doi: 10.1111/imr.12479. Review.

PMID:
27782324
19.

Lipoma of the Thumb: Spindle Cell Subtype.

El Rayes J, Bou Sader R, Saliba E.

Case Rep Orthop. 2016;2016:9537175. doi: 10.1155/2016/9537175. Epub 2016 Mar 21.

20.

Heme: Modulator of Plasma Systems in Hemolytic Diseases.

Roumenina LT, Rayes J, Lacroix-Desmazes S, Dimitrov JD.

Trends Mol Med. 2016 Mar;22(3):200-213. doi: 10.1016/j.molmed.2016.01.004. Epub 2016 Feb 12. Review.

PMID:
26875449
21.

Platelet GPVI repairs its own damage.

Rayes J, Watson SP.

Blood. 2015 Aug 20;126(8):933-4. doi: 10.1182/blood-2015-06-650838.

22.

The interaction between factor H and VWF increases factor H cofactor activity and regulates VWF prothrombotic status.

Rayes J, Roumenina LT, Dimitrov JD, Repessé Y, Ing M, Christophe O, Jokiranta TS, Halbwachs-Mecarelli L, Borel-Derlon A, Kaveri SV, Frémeaux-Bacchi V, Lacroix-Desmazes S.

Blood. 2014 Jan 2;123(1):121-5. doi: 10.1182/blood-2013-04-495853. Epub 2013 Sep 6.

23.

Mutations in the A3 domain of von Willebrand factor inducing combined qualitative and quantitative defects in the protein.

Legendre P, Navarrete AM, Rayes J, Casari C, Boisseau P, Ternisien C, Caron C, Fressinaud E, Goudemand J, Veyradier A, Denis CV, Lenting PJ, Christophe OD.

Blood. 2013 Mar 14;121(11):2135-43. doi: 10.1182/blood-2012-09-456038. Epub 2013 Jan 18.

24.

In vivo analysis of the role of O-glycosylations of von Willebrand factor.

Badirou I, Kurdi M, Legendre P, Rayes J, Bryckaert M, Casari C, Lenting PJ, Christophe OD, Denis CV.

PLoS One. 2012;7(5):e37508. doi: 10.1371/journal.pone.0037508. Epub 2012 May 17.

25.

Activation state of platelets in experimental severe hemophilia A.

Teyssandier M, Delignat S, Rayes J, Bryckaert M, Jandrot-Perrus M, Kaveri SV, Lacroix-Desmazes S.

Haematologica. 2012 Jul;97(7):1115-6. doi: 10.3324/haematol.2012.065235. Epub 2012 Mar 14. No abstract available.

26.

von Willebrand factor clearance does not involve proteolysis by ADAMTS-13.

Badirou I, Kurdi M, Rayes J, Legendre P, Christophe OD, Lenting PJ, Denis CV.

J Thromb Haemost. 2010 Oct;8(10):2338-40. doi: 10.1111/j.1538-7836.2010.04012.x. No abstract available.

27.

Mutation and ADAMTS13-dependent modulation of disease severity in a mouse model for von Willebrand disease type 2B.

Rayes J, Hollestelle MJ, Legendre P, Marx I, de Groot PG, Christophe OD, Lenting PJ, Denis CV.

Blood. 2010 Jun 10;115(23):4870-7. doi: 10.1182/blood-2009-11-254193. Epub 2010 Mar 3.

28.

Molecular characterization of four ADAMTS13 mutations responsible for congenital thrombotic thrombocytopenic purpura (Upshaw-Schulman syndrome).

Hommais A, Rayes J, Houllier A, Obert B, Legendre P, Veyradier A, Girma JP, Ribba AS.

Thromb Haemost. 2007 Sep;98(3):593-9.

PMID:
17849048
29.

Effect of von Willebrand disease type 2B and type 2M mutations on the susceptibility of von Willebrand factor to ADAMTS-13.

Rayes J, Hommais A, Legendre P, Tout H, Veyradier A, Obert B, Ribba AS, Girma JP.

J Thromb Haemost. 2007 Feb;5(2):321-8. Epub 2006 Nov 1.

30.

Comparison of FRETS-VWF73 to full-length VWF as a substrate for ADAMTS13 activity measurement in human plasma samples.

Mahdian R, Rayes J, Girma JP, Houllier A, Obert B, Meyer D, Veyradier A.

Thromb Haemost. 2006 Jun;95(6):1049-51. No abstract available.

PMID:
16732393
31.

CHO cells expressing the high affinity alpha(IIb)beta3 T562N integrin demonstrate enhanced adhesion under shear.

Legendre P, Salsmann A, Rayes J, Trassard O, Kieffer N, Baruch D.

J Thromb Haemost. 2006 Jan;4(1):236-46.

32.

Begg series II. Records and diagnostic technique.

Rayes JG.

JPO J Pract Orthod. 1968 Oct;2(8):402-13. No abstract available.

PMID:
5247607

Supplemental Content

Support Center